Li Jing, Dreyer Rachel P, Li Xi, Du Xue, Downing Nicholas S, Li Li, Zhang Hai-Bo, Feng Fang, Guan Wen-Chi, Xu Xiao, Li Shu-Xia, Lin Zhen-Qiu, Masoudi Frederick A, Spertus John A, Krumholz Harlan M, Jiang Li-Xin
National Clinical Research Center of Cardiovascular Diseases, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100037, China.
Chin Med J (Engl). 2016 Jan 5;129(1):72-80. doi: 10.4103/0366-6999.172596.
Despite the rapid growth in the incidence of acute myocardial infarction (AMI) in China, there is limited information about patients' experiences after AMI hospitalization, especially on long-term adverse events and patient-reported outcomes (PROs).
The China Patient-centered Evaluative Assessment of Cardiac Events (PEACE)-Prospective AMI Study will enroll 4000 consecutive AMI patients from 53 diverse hospitals across China and follow them longitudinally for 12 months to document their treatment, recovery, and outcomes. Details of patients' medical history, treatment, and in-hospital outcomes are abstracted from medical charts. Comprehensive baseline interviews are being conducted to characterize patient demographics, risk factors, presentation, and healthcare utilization. As part of these interviews, validated instruments are administered to measure PROs, including quality of life, symptoms, mood, cognition, and sexual activity. Follow-up interviews, measuring PROs, medication adherence, risk factor control, and collecting hospitalization events are conducted at 1, 6, and 12 months after discharge. Supporting documents for potential outcomes are collected for adjudication by clinicians at the National Coordinating Center. Blood and urine samples are also obtained at baseline, 1- and 12-month follow-up. In addition, we are conducting a survey of participating hospitals to characterize their organizational characteristics.
The China PEACE-Prospective AMI study will be uniquely positioned to generate new information regarding patient's experiences and outcomes after AMI in China and serve as a foundation for quality improvement activities.
尽管中国急性心肌梗死(AMI)的发病率迅速增长,但关于AMI患者住院后的经历,特别是长期不良事件和患者报告结局(PROs)的信息有限。
中国以患者为中心的心脏事件评估(PEACE)-AMI前瞻性研究将从中国各地53家不同医院连续招募4000例AMI患者,并对他们进行为期12个月的纵向随访,以记录他们的治疗、康复及结局。患者病史、治疗及住院结局的详细信息从病历中提取。正在进行全面的基线访谈,以描述患者的人口统计学特征、危险因素、临床表现及医疗服务利用情况。作为这些访谈的一部分,使用经过验证的工具来测量PROs,包括生活质量、症状、情绪、认知及性活动。出院后1个月、6个月和12个月进行随访访谈,测量PROs、药物依从性、危险因素控制情况并收集住院事件。收集潜在结局的支持文件,由国家协调中心的临床医生进行判定。在基线、1个月和12个月随访时也采集血液和尿液样本。此外,我们正在对参与研究的医院进行调查,以描述其组织特征。
中国PEACE-AMI前瞻性研究将处于独特地位,能够生成有关中国AMI患者经历和结局的新信息,并为质量改进活动奠定基础。